Why the study?
Does HOE 694 improve regional wall function and prevent ventricular fibrillation in a porcine model of ischemia/reperfusion?
Population
Porcine model of ischemia/reperfusion induced by coronary occlusion (n=19)
Comparison
HOE 694 7 mg/kg bolus 20 min before ischemia… vs Vehicle
Design
Preclinical
Follow-up
4 hours
Key result
HOE 694 significantly improved regional wall function (% segment shortening 74.1 vs 50.9, p<0.005) and completely prevented ventricular fibrillation in a porcine model of ischemia/reperfusion.
Authors
Loading...
Hypothesis-generating for Na+/H+ inhibition in ischemia/reperfusion; should not change clinical practice without human trials.
Does HOE 694 improve regional wall function and prevent ventricular fibrillation in a porcine model of ischemia/reperfusion?
Inhibition of the Na+/H+ antiporter with HOE 694 diminishes myocardial ischemic cell injury and prevents ventricular fibrillation in a porcine model.
Absolute Event Rate: 74.1% vs 50.9%
p-value: p=< 0.005
Sack et al. (1994) studied Ischemia/reperfusion (n=19). HOE 694 vs. Vehicle was evaluated on Regional wall function (percentage of segment shortening) (p=< 0.005). HOE 694 significantly improved regional wall function (% segment shortening 74.1 vs 50.9, p<0.005) and completely prevented ventricular fibrillation in a porcine model of ischemia/reperfusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: